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Two reports in this issue of Cell Host & Microbe establish that Nod-like receptor proteins NOD1 and NOD2
regulate stem cell function. Burberry et al. (2014) demonstrate that NOD1 and NOD2 synergize with TLRs
to mobilize hematopoietic stem cells. Nigro et al. (2014) report that NOD2 provides cytoprotection to intes-
tinal stem cells.The host-encoded pattern-recognition
molecules (PRMs) nucleotide-binding
oligomerization domain 1 (NOD1, also
referred to as NRLC1) and NOD2
(NLRC2), which belong to the Nod-like re-
ceptor (NLR) protein family, are known to
sense distinct bacterial peptidoglycan
(PGN) fragments derived from pathogens,
commensals, and pathobionts to instruct
innate and adaptive antimicrobial immu-
nity and regulate mucosal immune ho-
meostasis (Fritz et al., 2006). Now, two
recent reports from Nigro et al. (2014)
and Burberry et al. (2014) published in
this issue of Cell Host & Microbe extend
our knowledge of how these NLR proteins
instruct immunity by demonstrating that
PGN sensing by NOD1 and NOD2 regu-
late key biological functions of hemato-
poietic stem cells (HSCs) and intestinal
stem cells (Figure 1).
During infection and inflammation, im-
mune cells are in high demand and are
quickly consumed at the sites of need.
While adaptive immune cells have high
proliferative capacity, innate immune cells
are mostly postmitotic and need to be
rapidly replenished from bone marrow(BM) hematopoietic stem and progenitor
cells. It is estimated that in an adult hu-
man, 3 3 105 erythrocytes and 3 3 104
white blood cells are produced per sec-
ond at steady state, and upon infectious
challenge the cellular production can in-
crease several-fold over baseline levels.
Obviously, such high cellular throughput
requires a tight hierarchical control that
is organized with the HSCs at the top.
The majority of HSCs reside in the BM
within the stem cell niche, while a smaller
subset of HSCs reside in the spleen and
serve as a site for hematopoiesis during
embryogenesis and periods of duress.
Although niche support is essential for
their maintenance, HSCs traffic through
the bloodstream and through peripheral
tissues and have the potential to serve
as a local source for cell production.
While much is known about HSC regu-
lation and activity under homeostatic con-
ditions, how HSC throughput is regulated
during infection and inflammation and
the contributions of distinct PRMs is less
clear. Recent work utilizing Toll-like
receptor (TLR)-deficient settings and
application of purified TLR agonists hasprovided evidence that indirect as well
as direct activation of HSCs by TLR ago-
nists is critical for demand-adapted he-
matopoiesis during microbial encounter
(Takizawa et al., 2012). In settings of
systemic infection, microbe-associated
molecular patterns (MAMPs) activating
TLR signaling are elevated in circulation
and reach the BM, where they directly
act on TLR-expressing HSCs and instruct
enhanced generation of a lineage on de-
mand. Upon encounter of invading patho-
gens in peripheral tissues, microbe-medi-
ated triggering of TLR on HSCs induces
migration arrest and promotes HSC
proliferation and differentiation to ensure
local supply of myeloid effector cells. Dur-
ing the course of an immune response,
when certain lineages are in high demand
at specific sites, TLR ligation on lineage-
committed progenitors in the BM is
thought to cause mobilization from the
BM and recruitment to these sites,
where they proliferate and differentiate in
response to local pathogens to replenish
immune effector cells (Ya´n˜ez et al., 2013).
As Escherichia coli is commonly iso-
lated from the blood of humans suffering15, June 11, 2014 ª2014 Elsevier Inc. 659
Figure 1. Regulation of Stem Cells by Nod-like Receptors
(A) E. coli infection triggers NOD1, NOD2, and TLR4 signaling that synergistically lowers CXCL12 levels
in bone marrow and induces the release of G-CSF, leading to the accumulation of HSCs to give rise to
neutrophils and monocytes to enhance antimicrobial immunity.
(B) Microbiota-derived peptidoglycan triggers NOD2 signaling in Lgr5+ intestinal epithelial stem cells to
enhance cell viability and maintain gut epithelial regeneration.
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rodents with this Gram-negative bacte-
rium to study the mechanisms by which
systemic bacterial infection influences
localization and function of HSCs. The
authors demonstrate that infection with
E. coli increases the number of HSCs
in the spleen and moderately reduces
HSCs in the BM. Importantly, splenic
HSC accumulation was greatly dimin-
ished in TLR4/mice and partially dimin-
ished in animals lacking the adaptor pro-
tein receptor-interacting serine-threonine
kinase 2 (RIPK2), an essential down-
stream component of both NOD1 and
NOD2 signaling, suggesting that during
infection the synergistic activation of
TLR4 and NOD1/NOD2 is required.
Interestingly, administration of the TLR4
agonist lipopolysaccharide (LPS) did
not induce splenic HSC accumulation,
while coadministration of LPS and NOD1
agonists was sufficient, highlighting a
previously unappreciated role for NLR
signaling in promoting extramedullary
hematopoiesis. Activation of TLR4 and
NOD1 synergistically induced granulo-
cyte colony-stimulating factor (G-CSF),
which was required for splenic HSC accu-
mulation. Mechanistically, Burberry et al.660 Cell Host & Microbe 15, June 11, 2014 ªfurther show in a set of elegant experi-
ments that TLR4 and RIPK2 expression
in radio-resistant cells was required
for splenic HSC accumulation, while
TLR4 expression on HSCs was dispens-
able. These observations are in agree-
ment with a recent report demonstrating
that LPS-induced G-CSF-mediated
emergency myelopoiesis depends on
TLR4-expressing nonhematopoietic cells
(Boettcher et al., 2012). Future experi-
ments will be required to define the non-
hematopoietic cell type(s) that produce
G-CSF upon PRM stimulation.
Whether the accumulation of splenic
HSCs that occurs following infection is
due to expansion of resident HSCs or
mobilization of HSCs from the BM also re-
mains to be determined. In support
of mobilization, Burberry et al. (2014)
observed that less than 5% of splenic
HSCs were actively cycling at a time
when their numbers were rapidly
increasing. As such it remains to be es-
tablished whether the increase of splenic
HSCs is due to an active recruitment pro-
cess or due to inhibition of steady-state
egress. Another possibility is that infec-
tion and/or PRM-mediated inflamma-
tion regulates the BM stem cell niche.2014 Elsevier Inc.CXCL12 is a chemokine critical for reten-
tion of HSC in the BM niche, and downre-
gulation of CXCL12 is a common feature
of G-CSF-mediated mobilization. Indeed,
CXCL12 expression in BM was reduced
after E. coli infection or dual stimulation
of TLR4 and NOD1, suggesting that the
PRM activation of stromal cells might
regulate G-CSF and CXCL12 levels in
parallel. As distinct cellular sources and
niches in BM regulate HSC residency
and function (Frenette et al., 2013), which
specific cell type(s) are regulated by
distinct PRMs remains to be examined.
Functionally, Burberry et al. further
demonstrated that infection-induced
accumulation of splenic HSCs and pro-
genitor cells gives rise to neutrophils and
monocytes, which contribute to limit sec-
ondary infection. Therefore, it is likely that
the accumulation of HSCs in the spleen
provides an additional source for the gen-
eration of effector cells during infection
and inflammation, highlighting a previ-
ously unappreciated role for the synergis-
tic function of TLR and NLR signaling.
Recognition of bacterial PGN by NOD1
and NOD2 is also critical for the regulation
of intestinal immune homeostasis. The
intestinal microbiota protects the host
against pathogenic microorganisms, in-
creases its metabolic capacities, and
shapes maturation of the local and sys-
temic innate and adaptive immune sys-
tem. The beneficial effects of microbiota
on gut homeostasis occur in part through
direct sensing of bacterial products by
PRM. NOD1- and NOD2-mediated PGN
recognition of intestinal bacteria has
been shown to be critical for intestinal
lymphoid tissue formation (Bouskra
et al., 2008), and polymorphisms in
NOD2 are linked to Crohn’s disease (CD)
(Rosenstiel et al., 2009). Despite the
strong association betweenCD and caus-
ative NOD2 variants, a comprehensive
picture of how NOD2 contributes to dis-
ease pathogenesis has not yet emerged.
NOD2 is broadly expressed in myeloid
cells and at lower levels in lymphoid as
well as nonhematopoietic cells, including
intestinal epithelial cells (IECs). NOD2
is activated by N-acetyl muramyl dipep-
tide (MDP), a component of the PGN of
Gram-negative and Gram-positive bacte-
ria. Common CD-associated NOD2 vari-
ants abrogate RIPK2 binding and subse-
quent downstream signaling, suggesting
a hypomorphic function of CD-associated
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phisms have been suggested to encode
a gain-of-function aspect by actively
suppressing transcription of the immune
suppressive cytokine interleukin (IL)-10.
Furthermore, Nod2-deficient mice exhibit
decreased expression of specific antimi-
crobial a-defensins by epithelial cells,
and patients with CD-associated NOD2
variants expressed decreased levels
of a-defensins, suggesting that altered
NOD2 function in CD leads to a reduction
in the antimicrobial and anti-inflammatory
response, contributing to chronic intesti-
nal inflammation (Fritz et al., 2011).
A report published in this issue by Nigro
et al. (2014) highlights a previously unrec-
ognized role for NOD2 in intestinal ho-
meostasis. Utilizing intestinal organoid
culture systems (Barker et al., 2012), the
authors tested the specific role of MAMPs
activating TLR or NLR to monitor their
effects on the yield and development
of organoids. While stimulations with ago-
nists activating TLR2, TLR4, TLR5, TLR9,
and NOD1 had no influence on organoid
growth, selective stimulation of NOD2
yielded an increase of organoids. As no
change in the proliferative capacity of
crypt cells was observed, Nigro et al. hy-
pothesized that in the presence of MDP,
more crypt and/or intestinal stem cells
could survive and generate organoids.
Indeed, cultures of Lgr5+ intestinal stemcells only or Lgr5+ intestinal stem cells
cocultured with paneth cells yielded
enhanced organoid growth upon stimula-
tion with the NOD2 agonist. As NOD2
expression was found to be high in
Lgr5+ intestinal stem cells but low in pan-
eth cells, the authors reasoned that
enhanced organoid growth results from
direct stimulation of stem cells by MDP
exerting cytoprotective effects. To sub-
stantiate their hypothesis, Nigro et al.
reduced the microbiota content of mice
by antibiotic treatment and administered
doxorubicin to induce oxidative stress
and injury in intestinal epithelial stem cells
in the absence or presence of MDP.
Importantly, the reduced frequency of
proliferating crypt cells upon doxorubicin
treatment could be reversed by MDP
administration, and the effect was NOD2
dependent. Moreover, doxorubicin treat-
ment led to increased cell death in
NOD2/ animals, demonstrating that
NOD2-mediated PGN recognition by in-
testinal stem cells exerts a cytoprotective
function. Future experiments will have to
decipher if NOD2 expression solely in in-
testinal epithelial cells is responsible for
the observed function or whether other
NOD2-expressing cells, such as mesen-
chymal and/or hematopoietic cells, also
play a role. As the NOD2-mediated cyto-
protective effect may have major positive
medical benefits, studies detailing the un-Cell Host & Microbederpinning molecular mechanisms are of
utmost importance.REFERENCES
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